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Abstract
Clostridium difﬁcile infection is most often induced by antibiotic treatment. Recently, morbidity and mortality resulting especially from
C. difﬁcile PCR ribotype 027 have increased signiﬁcantly. In addition, more severe disease has been associated with C. difﬁcile PCR ribo-
type 078 strains. Thus, reliable typing methods for epidemic control are needed. In the present study, we compared an automated
repetitive extragenic palindromic sequence-based PCR (rep-PCR) method (DiversiLab; Bacterial Barcodes, Inc., Athens, GA, USA) to
PCR ribotyping and pulsed-ﬁeld gel electrophoresis (PFGE) typing using 205 isolates of C. difﬁcile (including 24 previously characterized
isolates). Among the 181 clinical isolates, a total of 31 different PCR ribotypes, 38 different PFGE types and subtypes and 28 different
rep-PCR types were found. Six major rep-PCR groups (DL1–DL6) harboured 86% of the clinical isolates. All isolates belonging to PCR
ribotypes 027 and 001 clustered in their own rep-PCR groups, enabling us to screen out the hypervirulent ribotype 027 strain. Within
the PCR ribotype 001, four subgroups were found using rep-PCR. Overall, in 75% (135/181) of the isolates, the classiﬁcation attributed
following rep-PCR and PCR ribotyping was comparable. In conclusion, the automated rep-PCR-based typing method represents an
option for ﬁrst-line molecular typing in local clinical microbiology laboratories. The method was easy to use as well as rapid, requiring
less hands-on time than PCR ribotyping or PFGE typing. The conventional PCR ribotyping or PFGE, however, are needed for conﬁrma-
tory molecular epidemiology. In addition, more epidemiology-oriented studies are needed to examine the discriminatory power of auto-
mated rep-PCR with isolates collected from a larger geographical area and during a longer period of time.
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Introduction
Clostridium difﬁcile is the main causative agent of antibiotic-
associated diarrhoea. C. difﬁcile infection (CDI) can present as
severe disease, and particularly the PCR ribotype 027 has
been recently associated with increased virulence [1–3]. The
major risk factors for C. difﬁcile infection include high age, hos-
pitalization, immune-compromising conditions and exposure
to certain antimicrobial agents, especially ﬂuoroquinolones
and cephalosporines. The C. difﬁcile PCR ribotype 027 strain
has been found in both hospital and community environments,
as well as in soil, rivers, lakes and meat products [4,5]. It
is commonly associated with outbreaks with increased mor-
bidity and mortality [6]. The epidemic-associated C. difﬁcile
027 strain has a 18-bp deletion in the tcdC gene, the negative
regulator of toxin production [7], and produces the binary
toxin (CDT) [1–3,8]. Interestingly, McCannell et al. [9]
described a one-nucleotide deletion in the tcdC regulator gene
of C. difﬁcile 027 leading to a premature stop codon; the
authors suggested the production of a truncated TcdC
protein as a result of this deletion. The excessive toxin
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production characteristic for C. difﬁcile 027 is considered to
be a result of this defect in TcdC, with the normal inhibition
of toxin production before the stationary phase being missing
in these strains [1].
There are also deletions larger than 18 bp in the tcdC
ampliﬁcation products. Such deletions have been described
earlier by Stare et al. [10]. These large deletions do not lead
to truncations but result in amino acid deletions in the puta-
tive protein products. Curry et al. reported [11] that the
tcdC variants with these larger deletions also contain stop
codons comparable to the one detected in C. difﬁcile 027,
and thus these variants may be potential hyperpoducers of
toxins A and B. Recently, Goorhuis et al. [12] reported that
C. difﬁcile PCR ribotype 078 can also cause more severe CDI
and increased mortality. This ribotype has a 39-bp deletion
as well as a stop codon leading to a mutation in its tcdC
gene. Therefore, we chose to include also isolates possessing
these characteristics in the present study.
Healthcare institutions require accurate and rapid diagno-
sis for the early detection of possible outbreaks [13]. Strain
typing can help with the infection control procedures by
tracking the source and spread of C. difﬁcile infections. Sev-
eral molecular typing methods, such as PCR ribotyping,
pulsed-ﬁeld gel electrophoresis (PFGE) and multilocus vari-
able-number of tandem repeat analysis are used as tools with
C. difﬁcile [14]. PCR ribotyping is the reference standard in
typing C. difﬁcile in Europe and PFGE is the reference stan-
dard in the USA. Recently, an automated DiversiLab system
(Bacterial Barcodes, Inc., Athens, GA, USA) using repetitive
extragenic palindromic sequence-based PCR (rep-PCR) has
become available. The rep-PCR method uses primers that
target noncoding repetitive sequences interspersed through-
out the bacterial genome [15,16]. The ampliﬁed DNA frag-
ments, when separated by electrophoresis, constitute a
genomic ﬁngerprint that can be used for bacterial subspecies
discrimination and strain delineation [17]. The commercial
semi-automated rep-PCR device, DiversiLab, offers better
standardization and greater reproducibility than manual, gel-
based rep-PCR [16].
In the present study, we assessed the usefulness of the
DiversiLab semi-automated rep-PCR for typing C. difﬁcile and
compared these results with those obtained with PCR ribo-
typing and PFGE.
Materials and Methods
Bacterial strains and culture conditions
A total of 205 C. difﬁcile isolates from THL (National insti-
tute of Health and Welfare, former KTL) (99 consecutive
isolates collected from September 2007 to March 2008 from
hospitals in different regions of Finland) and from HUSLAB
(Laboratory of Helsinki University Central Hospital) (82 con-
secutive isolates collected from 1–18 January, 2008), and 24
isolates (collected from 5 November 2007 to 17 March
2008) with large (39 bp and 54 bp) deletions in tcdC were
studied. PCR analyses detecting virulence genes and screen-
ing for tcdC gene deletions were performed at HUSLAB [18]
and THL. Helsinki University Hospital is responsible for the
secondary and tertiary care of approximately 1.5 million peo-
ple. The culture samples from this area received by HUSLAB
are both from the hospitals as well as from outpatients of
this geographical area, the Helsinki and Uusimaa district in
southern Finland. The culture samples of HUSLAB analyzed
in the present study were from patients treated in 15 differ-
ent hospitals, as well as from patients in 16 different outpa-
tient clinics. The isolates with large deletions were chosen
subsequent to routine screening at the laboratory [18].
C. difﬁcile strains were cultured in anaerobic atmosphere on
CCFA plates (cycloserine–cefoxitin–fructose–egg yolk agar)
and incubated at 35C for 42 h. Colonies with typical mor-
phology, ﬂuorescence and odour were identiﬁed as C. difﬁcile.
Rep-PCR
DNA was extracted from colonies on CCFA plates using the
UltraClean microbial DNA isolation kit (Mo Bio Laborato-
ries, Solona Beach, CA, USA) and diluted to 25–50 ng/lL.
The DNA was ampliﬁed using the DiversiLab Clostridium kit
(catologue no DL-CD01; Bacterial Barcodes, Inc.) for DNA
ﬁngerprinting in accordance with the manufacturer’s instruc-
tions; 2 lL of genomic DNA, 18 lL of the rep-PCR master
mix, 2 lL of primer mix provided in the kit, 0.5 lL of Amp-
liTaq polymerase and 2.5 lL of 10· PCR buffer (Applied Bio-
systems Roche, Branchburg, NJ, USA) were added for a total
of 25 lL per reaction. PCR was run on a preheated thermal
cycler (DNA Engine Tetrad 2; Peltier Thermal Cycler Bio-
Rad, Hercules, CA, USA). The thermal cycling parameters
were: initial denaturation at 94C for 2 min, followed by 35
cycles of denaturation at 95C for 30 s, annealing at 60C
for 30 s, extension at 70C for 1.5 min, and ﬁnal extension
at 70C for 3 min. The speciﬁc positive and negative controls
included in the kit were run with each reaction set for the
validation of ampliﬁcation. The rep-PCR products were
detected and the amplicons separated using microﬂuidics lab-
on-a-chip technology and analyzed using the DiversiLab
system (Bacterial Barcodes, Inc.). Further analysis was per-
formed with the web-based DiversiLab software (version
3.4) using the band-based modiﬁed Kullback–Leibler distance
for the calculation of percent similarities. This calculation
places more weight on band presence than on intensity vari-
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ations. The automatically generated dendograms, similarity
matrices, electropherograms, virtual gel images, scatter plots
and selectable demographic ﬁelds were also used in the
interpretation.
The manufacturer provides guidelines for strain-level dis-
crimination; a similarity of more than 97% is considered as
indistinguishable (no differences in ﬁngerprints); a similarity
of more than 95% is considered as similar (one or two band
difference in ﬁngerprints); and a similarity of <95% is consid-
ered as different. In the present study, 90% similarity was
taken as the optimal cut-off for clustering.
tcdC gene sequencing
Whole-gene sequencing of tcdC was performed using isolates
with deletions >18 bp. The entire tcdC gene was ampliﬁed for
sequencing as described by Spigaglia and Mastrantonio [19].
PCR ribotyping
PCR ribotyping was performed according to the protocol of
the Anaerobe Reference Laboratory, Cardiff, UK [20], using
the Cardiff-ECDC culture collection as a set of reference
strains. After gel electrophoresis, the band patterns were
analyzed using the BioNumerics software, version 5.0
(Applied Maths NV, Sint-Martens-Latem, Belgium). If the gel
pattern of an isolate did not match any of the reference
strain patterns, it was given an intralaboratory ribotype name
(unknown 1, 2, 3, etc.).
PFGE
PFGE was performed as described previously [21], with slight
modiﬁcation. Separation was performed in 1.1% Seakem Gold
agarose in 0.5·TBE (0.045 M Tris-borate, 0.001 M EDTA)
with thiourea (200 lM) in a CHEF-DRIII system (Bio-Rad
Laboratories, Richmond, CA, USA). Running conditions con-
sisted of one block with switching times of 5 and 55 s, and a
running time of 21 h. The lambda ladder was used as DNA
size standard and the Cardiff-ECDC culture collection type
strains of C. difﬁcile PCR ribotype 027 and 001 as controls.
PFGE patterns were analyzed with BioNumerics (version 5.0)
using the Dice coefﬁcient to analyze the similarity of the
banding patterns, and the unweighted pair group method
using arithmetic averages (UPGMA) for cluster analysis. We
used a ‡ 80% relatedness to deﬁne the lineages [14].
Results
Clinical isolates
Rep-PCR ﬁngerprints were generated and PCR ribotyping
was performed for 181 clinical isolates (Fig. 1). The most
prevalent PCR ribotypes were 027 (n = 64, 31%) and 001
(n = 54, 26%) (Table 1). The rest of the isolates represented
a total of 29 different PCR ribotypes. With rep-PCR analysis,
a total of 28 different proﬁle groups were found when >90%
similarity was used as threshold (Fig. 1, Table 1). Six major
rep-PCR groups were detected (Fig. 1). In 75% (135/181) of
the isolates, the classiﬁcation obtained by rep-PCR and PCR
ribotyping (PCR ribotypes 027, 001, 023, 078 and unknowns
3, 9, 19, 22, 27, 30, 37, 53, 64, 66) were comparable (Fig. 1,
Table 1).
In PCR ribotype 027, a similarity of >90% was detected by
rep-PCR (data not shown). Within the PCR ribotype 001,
four rep-PCR subgroups and one outlier strain were
detected. Most of the PCR ribotype 001 strains (63%)
belonged to rep-PCR DL 2 sub. 1 group. The rep-PCR DL 2
sub. 2 group harboured 20%, whereas DL 2 sub. 3 and sub.
4 groups harboured both 7% of the isolates (Fig. 2). Both of
the main PCR ribotypes, 027 and 001, clustered in their own
rep-PCR groups when all the 181 clinical isolates were com-
pared with each other (data not shown). In addition, PCR
ribotype 027 and 001 both had a typical well identiﬁable
electropherogram (Fig. 1).
In 25% of the isolates, there were inconsistencies between
the PCR ribotyping and rep-PCR results (Figs 1 and 3,
Table 1). Instead, we found at least three cases where rep-
PCR and PCR ribotyping did not correlate, but PFGE sup-
ported the rep-PCR clustering.
First, an isolate representing PCR ribotype ‘unknown 44’
(one band difference vs. PCR ribotype 027), PFGE NAP 1
subtype 1 and with an 18 bp tcdC deletion clustered into the
same group with rep-PCR as isolates with PCR ribotype 027.
Second, an isolate with PCR ribotype ‘unknown 53’ (one
band difference vs. PCR ribotype 001) and PFGE type unique
3 clustered according to rep-PCR close to the group har-
bouring all other isolates of PCR ribotype 001 and PFGE
type unique 3. Third, an isolate with PCR ribotype ‘unknown
55’ and PFGE type unique 14 sub. 2 clustered into the same
rep-PCR group with PCR ribotype 023 and this isolate had a
54-bp deletion in tcdC as did the PCR ribotype 023 isolates.
As for the rest of the isolates, deﬁnite conclusions cannot be
made; only few representatives of each PCR ribotype, PFGE
type or DL type were found.
None of the three methods was coherently more discrim-
inative than the other two. Among the PCR ribotypes 002,
005, 012, 014, 018, 020, 056, 070 and the ‘unknown 52’, the
rep-PCR was more discriminative than PCR ribotyping. As
for the PCR ribotypes 014 and the ‘unknown 52’, PFGE was
also more discriminative than PCR ribotyping. This is shown
in Fig. 3 for ribotypes 002, 014 and 020. In addition, the larg-
est rep-PCR group (DL 3), after the two harbouring PCR
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FIG. 1. Repetitive extragenic palindromic sequence-based PCR (rep-PCR) results for the 181 clinical isolates analyzed. Of PCR ribotype 027
belonging to (DL 1) and 001 (DL 2), a representative set of ﬁve isolates is included (between red dashed lines). The six largest rep-PCR groups
(DL 1–6) with >90% similarity are numbered. The typical electropherograms of PCR ribotypes 001 and 027 are shown. (Unknown, intralaborato-
ry ribotype name; ribotype, PCR ribotype according to Cardiff-ECDC; PFGE, pulsed-ﬁeld electrophoresis; DL, DiversiLab).
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ribotypes 001 and 027, included isolates from several PCR
ribotypes (002, 014, 018, 020, ‘unknown 10’, ‘unknown 11’
and ‘unknown 63’) and PFGE types (Fig. 1). Over half (52%)
of the PCR ribotype 002, 014 and 020 isolates were grouped
into the rep-PCR group DL 3. The similarity percentages
determined with rep-PCR varied between 7.7% and 99.2%
among the isolates belonging to PCR ribotypes 002, 014 and
020.
tcdC-A and tcdC-A variants
In addition, isolates with large tcdC deletions (n = 24) were
studied (sequencing results not shown). The tcdC-A gene
(classiﬁcation as in Curry et al. [11]) has a 39-bp deletion
(nucleotides 341–367) and the tcdC-A variant (tcdC-Avar) had a
54-bp deletion in the same location as tcdC-A (nucleotides
313–367) [4]. Of the isolates possessing tcdC-A, three differ-
ent PCR ribotypes, 045, 078 and 126, were detected. These
ribotypes, however, fell into two different rep-PCR groups
with four additional outliers (Fig. 4). With these isolates,
PFGE supported neither PCR ribotyping, nor rep-PCR but
led to a third delineation of isolates. All the isolates having a
tcdC-Avar allele were of PCR ribotype 023 with one exception
(PCR ribotype ‘unknown 55’). Using rep-PCR, this particular
isolate was indistinguishable from the main clone harbouring
11 out of 14 isolates of this population (Figs 1 and 4). Using
PFGE, these tcdC-Avar isolates represented the PFGE type
‘unique 14’ and its three subtypes (Fig. 4).
Reproducibility of rep-PCR
The effect of DNA isolation and PCR conditions, and techni-
cian skills on the electropherogram for each isolate type was
studied with a set of isolates including PCR ribotypes 027,
001, 078 and ‘unknown 55’ (Fig. 5).
The DNA isolation step had to be carried out optimally
to obtain reproducible results. Independent of this, with
some isolates, the freezing-melting cycle of the template
DNA between separate PCRs appeared to result in some-
what distinct rep-PCR proﬁles.
Discussion
We studied a set of clinical C. difﬁcile isolates by PCR ribo-
typing, PFGE and rep-PCR aiming to assess the utility of the
TABLE 1. The groupings obtained
with PCR ribotyping, repetitive
extragenic palindromic sequence-
based PCR (rep-PCR) [DiversiLab
(DL)] and pulsed-ﬁeld electropho-
resis (PFGE) for a total of 181 clin-
ical isolates
PCR ribotype
Number of
isolates Rep-PCRa (DLb) PFGE
027 64 DL 1 NAP1, sub. 1 and 2
001 54 DL 2 sub.1,2,3,4 Unique 3 and unique 3 sub. 1
023 4 DL 5 Unique 14 sub. 1 and 2
078 2 DL 9 Unique 11 sub. 1 and
unique 13 sub. 2
005 2 DL 18, DL 28 Unique 5 sub. 2
Unknown 3 1 DL 15 Unique 22 sub. 1
020 8 DL 3, DL 6, DL 11 Unique 1, unique 1 sub.
4 and 5
002 6 DL 3, DL 4, DL 6, DL 25 Unique 21, unique 21
sub.1, 2 and 4
012 2 DL 7, DL 16 Unique 1 sub. 3 and ND
017 1 DL 17 ND
Unknown 10 1 DL 3 ND
Unknown 11 1 DL 3 ND
014 11 DL 3, DL 6, DL 11, DL 12, DL 21, DL 22 Unique 1, unique 1 sub. 2,
unique 15, unique 15 sub.
3 and ND
056 2 DL 4, DL 8 Unique 15 sub. 4 and ND
003 1 DL 4 Unique 7
018 3 DL 3, DL 8 Unique 6 and unique 6 sub. 1
Unknown 19 1 DL 19 ND
010 1 DL 4 Unique 3
Unknown 22 2 DL 10 Unique 5 sub. 1 and 3
029 1 DL 26 Unique 5 sub. 3
Unknown 30 1 DL 20 Unique 29
070 2 DL 4, DL 13 Unique 7
011 1 DL 23 Unique 1 sub. 1
Unknown 44 1 DL 1 NAP1 sub. 1
Unknown 52 2 DL 4, DL 7 Unique1 sub. 4
and unique-28
Unknown 53 1 DL 27 Unique 3
Unknown 55 1 DL 5 Unique 14 sub. 1
Unknown 63 1 DL 3 Unique 13 sub. 3
Unknown 64 1 DL 14 Unique 1
Unknown 66 1 DL 24 Unique 1 sub. 4
Unknown 68 1 DL 7 Unique 18 sub. 1
181
Members of the six major rep-PCR groups (DL 1–6) are shown in red.
ND, not determined.
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automated rep-PCR for typing. The correlation of rep-PCR,
PCR ribotyping and PFGE was excellent with the two major
groups of isolates, PCR ribotypes 027 and 001. Among other
isolates, the grouping obtained with these three methods
was less coherent.
The automated rep-PCR method proved to be easy to
use with good reproducibility. A set of 13 samples could
be analyzed within a single day. The current European ref-
erence method, PCR ribotyping, can be performed in
2 days for a set of 17 samples [22]; using capillary gel elec-
trophoresis-based PCR ribotyping, at least 90 isolates can
be typed per diem [23]. By contrast, PFGE is considered a
labour-intensive, time-consuming method that yields optimal
results when performed by a technician with extensive
experience. In practice, the rep-PCR proﬁles were easily
stored in the web-based library and conveniently analyzed
by the software of the system. We found this especially
beneﬁcial in everyday diagnostic work; the proﬁles of
isolates analyzed at separate timepoints can be archived in
the library and compared at chosen timepoints. We found
the library generated by us to be more useful than the one
provided by the manufacturer, which does not allow
direct PCR ribotype or PFGE type vs. rep-PCR proﬁle
comparison.
The rapid clonal spread of the hypervirulent PCR ribotype
027 strain has created the need for rapid detection of iso-
lates belonging to this clone. The PCR ribotype 027 strains
were clearly separated into one cluster using rep-PCR. Thus,
the rep-PCR method can be used for screening hypervirulent
PCR ribotype 027 strains for which a typical electrophero-
gram was detected. The two other potentially hypervirulent
toxin hyperproducers (1-bp deletion leading to stop codon
in tcdC) (e.g. PCR ribotypes 023 and 078) were also found
to cluster in their own rep-PCR groups.
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Within the PCR ribotype 001, rep-PCR was more discrim-
inatory than ribotyping, differentiating four subgroups
(Fig. 2). This phenomenon has also been reported by others
who used in-house rep-PCR [24,25]. Healy et al. (19th
European Congress of Clinical Microbiology and Infectious
Diseases, abstract P1731) have also tested the DiversiLab-
system in the typing of C. difﬁcile. In their study, in addition
to PCR ribotype 001, types 002, 027, 053, 078 and 106 also
were divided into several different rep-PCR proﬁles. The
most typical rep-PCR proﬁle of PCR ribotype 001 isolates in
the present study had only four to ﬁve peaks in the electro-
pherogram. Differences among these isolates could be found
mainly as a result of differences in the intensity of the peaks.
Healy et al. (19th European Congress of Clinical Microbiol-
ogy and Infectious Diseases, abstract P1731) compared rep-
PCR, PCR ribotyping and PFGE in the analysis of 73 isolates
from the UK and the USA. By contrast to the results
obtained in the present study, they found four different
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rep-PCR groups among the PCR ribotype 027 strains. More-
over, their PCR ribotype 023 isolate was identical to four
PCR ribotype 027 isolates in rep-PCR. However, the electro-
pherogram of this isolate appears to correspond quite closely
to the rep-PCR-proﬁles of our PCR ribotype 023 strains. The
discrepancies between our results and the results of Healy
et al. (19th European Congress of Clinical Microbiology and
Infectious Diseases, abstract P1731) may be a result of true
differences between the strains circulating in the three geo-
graphic areas of the UK, the USA and Finland). The emer-
gence of PCR ribotype 027 in Finland is rather recent. The
isolates of this type from Finland are most likely clonal, and
variation over time has not yet occured. In addition, Healy
et al. deﬁned the rep-PCR groups manually, whereas we used
the 90% cut-off value in addition to the manual comparison.
By contrast, grouping of some ribotypes into one rep-PCR
group could be detected (PCR ribotypes 014, 002 and 020).
These ribotypes differ from one another by only one band. In
our material 14% (25/181) of the strains presented these three
PCR ribotypes and most of them (52%) belonged to the third
largest rep-PCR group, DL 3. Interestingly, PCR ribotypes 014
and 002 are common PCR ribotypes among clinical isolates in
Europe [26]. However, to our knowledge, these types of iso-
lates have not been reported to cause more severe disease.
In the present study, we concentrated on comparing auto-
mated rep-PCR, PCR ribotyping and PFGE in a compact set
of consecutive samples without consideration of the associ-
ated epidemiological data. The samples were collected from
one European country during a limited time period. The use-
fulness of the rep-PCR with isolates collected from a larger
geographical area, or during a longer period of time remains
yet to be determined.
In conclusion, we found that DiversiLab, the rapid typing
method evaluated in the present study, is a useful tool for
clinical laboratories in locally monitoring the spread of C. dif-
ﬁcile (e.g. in hospital wards). It may even be adequate for a
local outbreak investigation when all the analyses are per-
formed in one laboratory. However, the results obtained
with the three methods analyzed showed discrepancies, and
therefore it is advisable to use multiple methods with a care-
fully focused purpose for each of them.
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